CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Medullary Thyroid Carcinoma
Related studies linked through entity extraction aliases.
Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
- Status
- RECRUITING
- Phase
- NA
PET-TC in Thyroid Evaluation
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma.
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- NA
Spanish Study for Molecular Characterization of Thyroid Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC
- Status
- COMPLETED
- Phase
- PHASE1
Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
- Status
- COMPLETED
- Phase
- N/A
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Collection of Tissue Samples for Study of Multidrug Resistance
- Status
- COMPLETED
- Phase
- N/A
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2